Note that the therapeutic indication for all of these drugs is for type 2 diabetes, with the exception of Wegovy (2.4 mg/week of semaglutide by subcutaneous injection), which was recently approved for weight loss
Got more energy, my cravings are way down, and Im even losin some little weight
The glucagon receptor agonism, whilst counterintuitive given glucagon's role in raising blood glucose, is thought to increase energy expenditure and promote hepatic fat oxidation whilst reducing lipogenesis effects that may offer potential benefits in metabolic dysfunction-associated steatotic liver disease (MASLD)
While dizziness and vertigo are not the same, dizziness can sometimes be a precursor to vertigo or can be experienced similarly by patients
Dermatologic findings associated with semaglutide use: A scoping review
Laser Skin Whitening For targeted dark spot reduction